Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| DMAC | DIAMEDICA THERAPEUTICS INC | $343.73M | 51,688,913 | 16.96% | 69.86% | Net Buying | Net Buying | ||
| NTGR | NETGEAR INC | $832.20M | 28,402,755 | 88.12% | 11.88% | Net Selling | Net Selling | ||
| ZYME | ZYMEWORKS INC | $1.26B | 69,683,492 | 53.28% | 46.72% | Net Buying | Net Buying | ||
| ENTA | ENANTA PHARMACEUTICALS INC | $233.45M | 21,377,923 | 56.45% | 43.55% | Net Selling | Net Selling | ||
| SMLR | SEMLER SCIENTIFIC INC | $425.49M | 14,804,693 | 62.03% | 37.97% | Net Buying | Net Buying | ||
| TRVI | TREVI THERAPEUTICS INC | $1.30B | 121,776,855 | 38.52% | 61.48% | Net Buying | |||
| BSVN | BANK7 CORP | $393.66M | 9,449,237 | 11.92% | 88.08% | Net Selling | Net Selling | ||
| AVTX | AVALO THERAPEUTICS INC | $216.36M | 13,152,356 | 8.80% | 91.20% | Net Selling | |||
| CEVA | CEVA INC | $650.31M | 23,882,243 | 68.73% | 31.27% | Net Buying | |||
| LBRX | LB PHARMACEUTICALS INC | N/A | 20,100,137 | 0.00% | 38.83% | Net Buying | Net Buying | ||
| KRRO | KORRO BIO INC | $303.80M | 9,390,903 | 24.31% | 75.69% | Net Buying | |||
| AKA | AKA BRANDS HOLDING CORP | $136.64M | 10,844,082 | 4.11% | 95.89% | Net Selling | Net Selling | ||
| CARL | CARLSMED INC | $321.63M | 26,581,134 | 0.00% | 54.33% | Net Buying | |||
| OMER | OMEROS CORP | $475.71M | 68,055,826 | 42.72% | 5.30% | ||||
| TBPH | THERAVANCE BIOPHARMA INC | $752.90M | 50,361,296 | 51.78% | 48.22% | Net Selling | Net Selling | ||
| CRVO | CERVOMED INC | $63.88M | 8,702,719 | 3.08% | 96.92% | Net Buying | |||
| RZLT | REZOLUTE INC | $849.09M | 90,811,368 | 42.15% | 57.85% | Net Buying | |||
| EYPT | EYEPOINT PHARMACEUTICALS INC | $757.96M | 68,811,736 | 25.81% | 74.19% | Net Selling | |||
| UTI | UNIVERSAL TECHNICAL INSTITUTE INC | $1.53B | 54,406,215 | 70.16% | 29.84% | Net Selling | Net Buying | ||
| TMHC | TAYLOR MORRISON HOME CORP | $5.76B | 97,725,037 | 97.06% | 2.94% | Net Selling | Net Selling | ||
| SGMT | SAGIMET BIOSCIENCES INC | $252.69M | 32,521,599 | 34.93% | 65.07% | Net Selling | |||
| MBX | MBX BIOSCIENCES INC | $753.72M | 33,424,371 | 37.95% | 62.05% | Net Buying | Net Buying | ||
| CRVS | CORVUS PHARMACEUTICALS INC | $561.09M | 74,514,039 | 56.07% | 41.67% | Net Buying | |||
| RIOT | RIOT PLATFORMS INC | $7.05B | 371,807,186 | 58.11% | 14.20% | Net Selling | Net Selling | ||
| ELVN | ENLIVEN THERAPEUTICS INC | $1.10B | 59,235,547 | 49.50% | 50.50% | Net Selling | Net Selling | ||
| TVRD | TVARDI THERAPEUTICS INC | $39.57M | 9,377,433 | 5.93% | 94.07% | Net Selling | |||
| ATR | APTARGROUP INC | $7.58B | 65,619,154 | 94.38% | 3.79% | Net Selling | Net Selling | ||
| BNTX | BIONTECH SE | $24.87B | 240,455,450 | 22.36% | 0.00% | ||||
| KYIV | KYIVSTAR GROUP LTD | $423.71M | 31,620,000 | 57.09% | 2.81% | ||||
| GT | GOODYEAR TIRE & RUBBER CO | $2.30B | 286,160,909 | 92.34% | 1.56% | Net Selling | |||
| ORIC | ORIC PHARMACEUTICALS INC | $1.20B | 97,122,987 | 81.42% | 18.58% | Net Selling | Net Selling | ||
| MSGS | MADISON SQUARE GARDEN SPORTS CORP | $5.18B | 24,059,407 | 70.65% | 3.15% | Net Selling | Net Selling | ||
| CCCC | C4 THERAPEUTICS INC | $168.67M | 71,170,815 | 75.18% | 24.82% | Net Selling | Net Buying | ||
| TYRA | TYRA BIOSCIENCES INC | $789.86M | 53,297,140 | 62.08% | 37.92% | Net Buying | Net Buying | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $59.22M | 48,540,200 | 41.13% | 58.87% | Net Selling | Net Selling | ||
| IBIO | IBIO INC | $28.30M | 19,654,636 | 8.49% | 91.51% | Net Buying | |||
| OCUL | OCULAR THERAPEUTIX INC | $2.30B | 213,047,472 | 73.71% | 17.20% | Net Selling | Net Selling | ||
| NEXN | NEXXEN INTERNATIONAL LTD | $248.00M | 62,000,000 | 61.82% | 0.00% | ||||
| TNGX | TANGO THERAPEUTICS INC | $1.01B | 134,593,998 | 60.58% | 39.42% | Net Selling | Net Selling | ||
| SLDB | SOLID BIOSCIENCES INC | $306.19M | 77,910,239 | 55.70% | 44.30% | Net Buying | Net Selling | ||
| CGEM | CULLINAN THERAPEUTICS INC | $431.40M | 59,014,667 | 56.12% | 43.88% | Net Buying | Net Buying | ||
| ALEC | ALECTOR INC | $127.02M | 101,212,329 | 59.85% | 40.15% | Net Selling | Net Selling | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $173.03M | 74,262,990 | 25.94% | 74.06% | Net Buying | |||
| PXLW | PIXELWORKS INC | $34.15M | 5,335,317 | 7.93% | 92.07% | Net Selling | Net Selling | ||
| VTYX | VENTYX BIOSCIENCES INC | $641.78M | 71,308,518 | 40.90% | 59.10% | Net Buying | |||
| RAPP | RAPPORT THERAPEUTICS INC | $955.15M | 36,497,920 | 70.43% | 29.57% | Net Selling | Net Selling | ||
| CMPX | COMPASS THERAPEUTICS INC | $528.24M | 138,282,498 | 72.63% | 27.37% | Net Selling | |||
| OLMA | OLEMA PHARMACEUTICALS INC | $545.64M | 68,634,329 | 73.04% | 26.96% | Net Buying | Net Selling | ||
| CBIO | CRESCENT BIOPHARMA INC | $172.68M | 13,892,562 | 13.05% | 86.95% | ||||
| DAWN | DAY ONE BIOPHARMACEUTICALS INC | $936.23M | 102,431,933 | 56.90% | 43.10% | Net Selling | Net Selling | ||
| VERA | VERA THERAPEUTICS INC | $1.54B | 63,823,665 | 66.54% | 33.46% | Net Buying | |||
| T | AT&T INC | $174.12B | 7,089,449,495 | 65.66% | 0.31% | Net Selling | Net Buying | ||
| PPTA | PERPETUA RESOURCES CORP | $2.30B | 107,569,862 | 56.53% | 43.47% | Net Buying | Net Selling | ||
| GHRS | GH RESEARCH PLC | $842.96M | 62,028,145 | 70.22% | 0.00% | ||||
| FNKO | FUNKO INC | $176.06M | 55,365,410 | 36.12% | 63.88% | Net Selling | Net Selling | ||
| APGE | APOGEE THERAPEUTICS INC | $3.30B | 59,596,409 | 90.93% | 9.07% | Net Selling | Net Selling | ||
| IMCR | IMMUNOCORE HOLDINGS PLC | $1.55B | 50,233,609 | 95.69% | 4.31% | Net Buying | Net Buying | ||
| CYRX | CRYOPORT INC | $427.07M | 50,066,968 | 92.41% | 4.60% | Net Buying | Net Buying | ||
| DNTH | DIANTHUS THERAPEUTICS INC | $1.08B | 32,159,982 | 53.74% | 46.26% | Net Buying | Net Buying | ||
| RCUS | ARCUS BIOSCIENCES INC | $2.13B | 107,973,536 | 63.80% | 36.20% | Net Buying | Net Selling | ||
| CNTA | CENTESSA PHARMACEUTICALS PLC | $3.02B | 134,073,436 | 89.96% | 10.04% | Net Selling | Net Selling | ||
| VOYG | VOYAGER TECHNOLOGIES INC | $1.57B | 59,547,781 | 29.22% | 4.41% | Net Buying | |||
| PEPG | PEPGEN INC | $148.91M | 32,799,724 | 70.82% | 19.27% | Net Buying | Net Buying | ||
| VNCE | VINCE HOLDING CORP | $36.31M | 12,968,548 | 0.27% | 99.73% | Net Selling | |||
| KPTI | KARYOPHARM THERAPEUTICS INC | $91.39M | 17,050,876 | 11.01% | 88.99% | Net Selling | Net Selling | ||
| VKTX | VIKING THERAPEUTICS INC | $4.12B | 113,036,344 | 67.38% | 8.97% | Net Selling | Net Selling | ||
| IIIV | I3 VERTICALS INC | $971.51M | 32,265,204 | 72.48% | 27.52% | Net Selling | Net Selling | ||
| KYTX | KYVERNA THERAPEUTICS INC | $300.56M | 43,245,667 | 50.86% | 49.14% | ||||
| CTMX | CYTOMX THERAPEUTICS INC | $339.42M | 80,621,293 | 85.98% | 14.02% | Net Selling | |||
| IVA | INVENTIVA SA | $392.22M | 95,662,391 | 5.15% | 0.00% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.